{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:50Z","timestamp":1790905490724,"version":"4.1.0"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Two patients with subacute sclerosing panencephalitis (SSPE) were treated safely and effectively with high doses of intravenous ribavirin combined with intraventricular alpha interferon. The ribavirin concentrations maintained in the serum and cerebrospinal fluid were higher than those which inhibit SSPE virus replication in vitro and in vivo.<\/jats:p>","DOI":"10.1128\/aac.45.3.943-945.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"943-945","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":47,"title":["High-Dose Intravenous Ribavirin Therapy for Subacute Sclerosing Panencephalitis"],"prefix":"10.1128","volume":"45","author":[{"given":"Mitsuaki","family":"Hosoya","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Pediatrics1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Shigeta","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Microbiology,2 School of Medicine, Fukushima Medical University, Fukushima 960-1295, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Mori","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Microbiology,2 School of Medicine, Fukushima Medical University, Fukushima 960-1295, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Tomoda","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Child Development, Kumamoto University School of Medicine, Kumamoto 860-0811,3 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Child Development, Kumamoto University School of Medicine, Kumamoto 860-0811,3 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Miike","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Child Development, Kumamoto University School of Medicine, Kumamoto 860-0811,3 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Pediatrics1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","unstructured":"Banks\n              G.\n              Fernandez\n              H.\n          Clinical use of ribavirin in measles: a summarized review\n          Clinical applications of ribavirin.\n              Smith\n              R. A.\n              Knight\n              V.\n              Smith\n              J. A. D.\n          1980\n          203\n          209\n          Academic Press\n          New York N.Y"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.532"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/clinids\/19.3.454","article-title":"Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin.","volume":"19","author":"Forni A. L.","year":"1994","unstructured":"Forni A. L. Schluger N. W. Roberts R. B. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin. Infect. Dis. 19 1994 454 462","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_5_2","first-page":"219","article-title":"Ribavirin response in measles pneumonia.","volume":"20","author":"Gururangan S.","year":"1990","unstructured":"Gururangan S. Stevens N. W. Morris D. J. Ribavirin response in measles pneumonia. J. Infect. Dis. 20 1990 219 221","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.653"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-3542(89)90072-7","article-title":"Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro.","volume":"12","author":"Hosoya M.","year":"1989","unstructured":"Hosoya M. Shigeta S. Nakamura K. De Clercq E. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antiviral Res. 12 1989 87 98","journal-title":"Antiviral Res."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.3.2.235"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.1.241"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/clpt.1987.70","article-title":"Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.","volume":"41","author":"Laskin O. L.","year":"1987","unstructured":"Laskin O. L. Longstreth J. A. Hart C. C. Scavuzzo D. Kalman C. M. Connor J. D. Roberts R. B. Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. Clin. Pharmacol. Ther. 41 1987 546 55","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/clind\/16.5.654","article-title":"Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of literature.","volume":"16","author":"Mustafa M. M.","year":"1993","unstructured":"Mustafa M. M. Witman S. D. Winick N. J. Bellini W. J. Timmons C. F. Siegel J. D. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of literature. Clin. Infect. Dis. 16 1993 654 660","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/infdis\/159.4.748","article-title":"Oral ribavirin therapy for subacute sclerosing panencephalitis.","volume":"159","author":"Ogle J. W.","year":"1989","unstructured":"Ogle J. W. Toltzis P. Parker W. D. Oral ribavirin therapy for subacute sclerosing panencephalitis. J. Infect. Dis. 159 1989 748 750","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(97)06088-1","article-title":"Randomised, double-blind, placebo-controlled trial of interferon \u03b1-2b with and without ribavirin for chronic hepatitis C.","volume":"351","author":"Reichard O.","year":"1998","unstructured":"Reichard O. Norkrans G. Fryden A. Braconier J.-H. Sonnerborg A. Weiland O. for the Swedish Study Group Randomised, double-blind, placebo-controlled trial of interferon \u03b1-2b with and without ribavirin for chronic hepatitis C. Lancet 351 1998 83 87","journal-title":"Lancet"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-3542(97)00055-7","article-title":"The cooperative effect of interferon-\u03b1 and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo.","volume":"37","author":"Takahashi T.","year":"1998","unstructured":"Takahashi T. Hosoya M. Kimura K. Ohno K. Mori S. Takahashi K. Shigeta S. The cooperative effect of interferon-\u03b1 and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. Antiviral Res. 37 1998 29 35","journal-title":"Antiviral Res."},{"key":"e_1_3_1_15_2","unstructured":"Tomoda A. S. Shiraishi M. Hosoya A. Hamada and T. Miike. Combined treatment with interferon-\u03b1 and ribavirin for SSPE. Pediatr. Neurol. in press."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.3.943-945.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.3.943-945.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:11:01Z","timestamp":1645463461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.45.3.943-945.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1128\/AAC.45.3.943-945.2001"],"URL":"https:\/\/doi.org\/10.1128\/aac.45.3.943-945.2001","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2000-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-11-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}